133 related articles for article (PubMed ID: 16501908)
21. Rapid evolution in colorectal cancer: therapy now and over the next five years.
de Gramont A
Oncologist; 2005 Oct; 10 Suppl 2():4-8. PubMed ID: 16272453
[TBL] [Abstract][Full Text] [Related]
22. Bevacizumab: new drug. Metastatic colorectal cancer: good in theory, not in practice.
Prescrire Int; 2006 Jun; 15(83):94-7. PubMed ID: 16764097
[TBL] [Abstract][Full Text] [Related]
23. Targeted agents for adjuvant therapy of colon cancer.
de Gramont A; Tournigand C; André T; Larsen AK; Louvet C
Semin Oncol; 2006 Dec; 33(6 Suppl 11):S42-5. PubMed ID: 17178286
[TBL] [Abstract][Full Text] [Related]
24. Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study.
Fuchs CS; Marshall J; Mitchell E; Wierzbicki R; Ganju V; Jeffery M; Schulz J; Richards D; Soufi-Mahjoubi R; Wang B; Barrueco J
J Clin Oncol; 2007 Oct; 25(30):4779-86. PubMed ID: 17947725
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy for colorectal cancer in the metastatic and adjuvant setting: past, present and future.
Sabharwal A; Kerr D
Expert Rev Anticancer Ther; 2007 Apr; 7(4):477-87. PubMed ID: 17428169
[TBL] [Abstract][Full Text] [Related]
26. [Chemotherapy for metastatic colorectal cancer].
Iwasa S; Shimada Y
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1467-74. PubMed ID: 18799899
[TBL] [Abstract][Full Text] [Related]
27. A retrospective study of bifractionated CPT-11 with LF5FU infusion (FOLFIRI-3) in colorectal cancer patients pretreated with oxaliplatin and CPT-11 containing chemotherapies.
Viel E; Demarchi MF; Chaigneau L; Nguyen T; Legat C; Stein U; Thiery-Vuillemin A; Limat S; Pivot X; Borg C
Am J Clin Oncol; 2008 Feb; 31(1):89-94. PubMed ID: 18376234
[TBL] [Abstract][Full Text] [Related]
28. [Drug therapy of colorectal carcinoma].
Ulrich-Pur H; Jech B; Scheithauer W; Kornek GV; Huber H
Wien Klin Wochenschr; 2002 Jun; 114(10-11):368-76. PubMed ID: 12708089
[TBL] [Abstract][Full Text] [Related]
29. Is there a role for mitomycin C in metastatic colorectal cancer?
Dimou A; Syrigos KN; Saif MW
Expert Opin Investig Drugs; 2010 Jun; 19(6):723-35. PubMed ID: 20433364
[TBL] [Abstract][Full Text] [Related]
30. Second line therapy for advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Brus C; Saif MW
JOP; 2010 Jul; 11(4):321-3. PubMed ID: 20601802
[TBL] [Abstract][Full Text] [Related]
31. Novel therapeutic approaches for metastatic colorectal cancer.
Hoff PM
Oncology (Williston Park); 2000 Nov; 14(11A):217-20. PubMed ID: 11195413
[TBL] [Abstract][Full Text] [Related]
32. [The present situation regarding postoperative adjuvant chemotherapy].
Shimada R; Nozawa K; Watanabe T
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1396-402. PubMed ID: 21918334
[TBL] [Abstract][Full Text] [Related]
33. American Society of Clinical Oncology 2010 colorectal update.
Murphy JE; Ryan DP
Expert Rev Anticancer Ther; 2010 Sep; 10(9):1371-3. PubMed ID: 20836671
[TBL] [Abstract][Full Text] [Related]
34. Metastatic colorectal cancer: recent advances in its clinical management.
Barugel ME; Vargas C; Krygier Waltier G
Expert Rev Anticancer Ther; 2009 Dec; 9(12):1829-47. PubMed ID: 19954294
[TBL] [Abstract][Full Text] [Related]
35. Sequential versus combination therapy in the treatment of patients with advanced colorectal cancer.
Shah U; Goldberg RM
Clin Colorectal Cancer; 2008 Sep; 7(5):315-20. PubMed ID: 18794063
[TBL] [Abstract][Full Text] [Related]
36. [Significance and problem of post-operative adjuvant chemotherapy for colorectal cancer].
Kato T; Hirai T
Nihon Geka Gakkai Zasshi; 1997 Mar; 98(3):396-402. PubMed ID: 9101548
[TBL] [Abstract][Full Text] [Related]
37. Should continuous infusion 5-fluorouracil become the standard of care in the USA as it is in Europe?
El-Khoueiry AB; Lenz HJ
Cancer Invest; 2006 Feb; 24(1):50-5. PubMed ID: 16466993
[TBL] [Abstract][Full Text] [Related]
38. Levamisole as a therapeutic agent for colorectal carcinoma.
Grem JL
Cancer Cells; 1990 May; 2(5):131-7. PubMed ID: 2201339
[TBL] [Abstract][Full Text] [Related]
39. [Adjuvant therapy of colon carcinoma: results of two Intergroup Studies (INT-0035 and INT-0089), a study by the German Cancer Aid 17-1A Study Group and the IMPACT Study].
Petrasch S; Schmiegel W
Z Gastroenterol; 1997 Jan; 35(1):49-52. PubMed ID: 9123959
[No Abstract] [Full Text] [Related]
40. New agents, combinations, and opportunities in the treatment of advanced and early-stage colon cancer.
Natarajan N; Shuster TD
Surg Clin North Am; 2006 Aug; 86(4):1023-43. PubMed ID: 16905422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
